De Pita O - Search Results

1

Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.

Frezzolini A, Teofoli P, Cianchini G, Barduagni S, Ruffelli M, Ferranti G, Puddu P, De Pita O. Frezzolini A, et al. Among authors: de pita o. Eur J Dermatol. 2002 Jan-Feb;12(1):27-31. Eur J Dermatol. 2002. PMID: 11809592

2

Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.

Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pità O, Puddu P. Amerio P, et al. Among authors: de pita o. Curr Drug Targets Inflamm Allergy. 2003 Mar;2(1):81-94. doi: 10.2174/1568010033344480. Curr Drug Targets Inflamm Allergy. 2003. PMID: 14561178 Review.

3

The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris.

Sinistro A, Calabresi V, Lupi F, Sera F, Frezzolini A, Ruffelli M, De Pità O, Camaioni D, Cianchini G, Di Zenzo G. Sinistro A, et al. Among authors: de pita o. Eur J Dermatol. 2015 Nov-Dec;25(6):578-85. doi: 10.1684/ejd.2015.2652. Eur J Dermatol. 2015. PMID: 26552329

4

T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30).

De Pitá O, Frezzolini A, Cianchini G, Ruffelli M, Teofoli P, Puddu P. De Pitá O, et al. Arch Dermatol Res. 1997 Nov;289(12):667-70. doi: 10.1007/s004030050259. Arch Dermatol Res. 1997. PMID: 9452886

5

Interleukin-16 expression and release in bullous pemphigoid.

Frezzolini A, Cianchini G, Ruffelli M, Cadoni S, Puddu P, De Pità O. Frezzolini A, et al. Among authors: de pita o. Clin Exp Immunol. 2004 Sep;137(3):595-600. doi: 10.1111/j.1365-2249.2004.02570.x. Clin Exp Immunol. 2004. PMID: 15320912 Free PMC article.

6

Activation of nickel-specific CD4+ T lymphocytes in the absence of professional antigen-presenting cells.

Nasorri F, Sebastiani S, Mariani V, De Pità O, Puddu P, Girolomoni G, Cavani A. Nasorri F, et al. Among authors: de pita o. J Invest Dermatol. 2002 Jan;118(1):172-9. doi: 10.1046/j.0022-202x.2001.01574.x. J Invest Dermatol. 2002. PMID: 11851891 Free article.

7

Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.

Cianchini G, Lupi F, Masini C, Corona R, Puddu P, De Pità O. Cianchini G, et al. Among authors: de pita o. J Am Acad Dermatol. 2012 Oct;67(4):617-22. doi: 10.1016/j.jaad.2011.11.007. Epub 2012 Jan 13. J Am Acad Dermatol. 2012. PMID: 22243765

8

Psoriasis: comparison of immunological markers in patients with acute and remission phase.

De Pità O, Ruffelli M, Cadoni S, Frezzolini A, Biava GF, Simom R, Bottari V, De Sanctis G. De Pità O, et al. Among authors: de sanctis g. J Dermatol Sci. 1996 Nov;13(2):118-24. doi: 10.1016/s0923-1811(96)00517-8. J Dermatol Sci. 1996. PMID: 8953411

9

Soluble CD30 in pediatric patients with atopic dermatitis.

Frezzolini A, Paradisi M, Ruffelli M, Cadoni S, De Pità O. Frezzolini A, et al. Among authors: de pita o. Allergy. 1997 Jan;52(1):106-9. doi: 10.1111/j.1398-9995.1997.tb02554.x. Allergy. 1997. PMID: 9062638

10

Febrile ulceronecrotic Mucha-Habermann's disease with fatal outcome.

Puddu P, Cianchini G, Colonna L, Girardelli CR, Ferranti G, De Pita O. Puddu P, et al. Among authors: de pita o. Int J Dermatol. 1997 Sep;36(9):691-4. doi: 10.1046/j.1365-4362.1997.00297.x. Int J Dermatol. 1997. PMID: 9352413 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters